Skip to main content

Advertisement

Table 2 Animal information and SD 31 treatment dosages (Groups 1–5)

From: Efficacy of four commercially available heartworm preventive products against the JYD-34 laboratory strain of Dirofilaria immitis

Treatment group Animal identification Sex Body weight (lb)     
Ivermectin/Pyrantel     Tablet administered Dose
(Group 1)     Ivermectin (μg) Pyrantel (mg) Ivermectin (μg/kg) Pyrantel (mg/kg)
  IDF-2 M 28.9 136 114 10.4 8.7
  UHH-2 M 25.8 136 114 11.6 9.7
  VTH-2 M 23.7 68 57 6.3 5.3
  IOF-2 M 23.1 68 57 6.5 5.4
  BFG-2 F 23.0 68 57 6.5 5.5
  PXC-2 F 20.4 68 57 7.3 6.1
  VVH-2 M 21.2 68 57 7.1 5.9
  GSC-2 F 19.4 68 57 7.7 6.5
Milbemycin/Spinosad     Tablet administered Dose
(Group 2)     Milbemycin (mg) Spinosad (mg) Milbemycin (mg/kg) Spinosad (mg/kg)
  FCG-2 F 23.5 9.3 560 0.9 52.4
  IUE-2 F 25.7 9.3 560 0.8 47.9
  UDH-2 M 23.4 9.3 560 0.9 52.6
  VCG-2 F 22.4 9.3 560 0.9 55.0
  TPH-2 M 26.7 9.3 560 0.8 46.1
  XBH-2 M 21.4 9.3 560 1.0 57.6
  EZG-2 F 22.5 9.3 560 0.9 54.8
  KUH-2 M 18.4 4.5 270 0.5 32.3
     Applicator tube Dose
Selamectin     Selamectin (mg) Selamectin (mg/kg)
(Group 3) OFF-2 M 25.5 120 10.4
  VUH-2 M 24.1 120 11.0
  EYE-2 F 23.0 120 11.5
  UKG-2 F 21.6 120 12.2
  AVG-2 F 22.3 120 11.8
  GPG-2 F 20.7 120 12.8
  GDE-2 F 20.8 120 12.7
  ZXG-2 F 19.0 60 6.9
Moxidectin/ Imidacloprid     Applicator tube Dose
(Group 4)     Moxidectin (mg) Imidacloprid (mg) Moxidectin (mg/kg) Imidaclopridd (mg/kg)
  DIH-2 M 24.4 NA NA NA NA
  UYH-2 M 27.1 NA NA NA NA
  CGH-2 M 23.6 NA NA NA NA
  FKC-2 F 22.1 NA NA NA NA
  FJC-2 F 20.8 NA NA NA NA
  VZG-2 F 20.6 NA NA NA NA
  LAG-2 F 20.7 NA NA NA NA
  THH-2 M 19.1 NA NA NA NA
Non-treated control      
(Group 5) UTH-2 M 28.1 NA NA NA NA
  GKC-2 F 25.2 NA NA NA NA
  TWH-2 M 22.8 NA NA NA NA
  EDG-2 F 21.5 NA NA NA NA
  RAF-2 M 23.5 NA NA NA NA
  CRC-2 F 21.6 NA NA NA NA
  TJH-2 M 22.5 NA NA NA NA
  IXG-2 F 19.5 NA NA NA NA